Trial intelligence / Profile preview

Tamsulosin vs placebo to prevent postoperative urinary retention after herniorrhaphy, varicocelectomy, and anorectal surgery

IRCT20181006041252N12Phase 3Completed

Sponsor
Sabzevar University of Medical Sciences
Start
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in urinary retention comparing Tamsulosin with Placebo (2 arms). Primary endpoint: Incidence of postoperative urinary retention. Started Jan 2019; status: completed.

02

Drugs

tamsulosin
03

Conditions

urinary retention

Beyond the preview

Go deeper on IRCT20181006041252N12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20181006041252N12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call